Unum Therapeutics Inc (NASDAQ:UMRX)

0.6619
Delayed Data
As of Feb 27
 -0.0204 / -2.99%
Today’s Change
0.48
Today|||52-Week Range
4.87
-8.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Operating ActivitiesNet Income / Starting Line-9.0M-10.2M-8.6M-11.7M
 
 
 
 
 
Depreciation325.0K330.0K352.0K330.0K
 
 
 
 
 
Total Other Cash Flow810.0K745.0K832.0K678.0K
 
 
 
 
 
Funds From Operations-7.9M-9.1M-7.4M-10.7M
 
 
 
 
 
Funds From/For Other Operating Expenses25.0K-1.5M1.6M835.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-7.9M-7.6M-9.0M-11.5M
 
 
 
 
 
 
InvestingIncrease In Investments-47.7M0.000.000.00
 
 
Decrease In Investments6.7M10.0M15.0M15.0M
 
 
 
 
 
Capital Expenditures-388.0K-86.0K0.00-42.0K
 
 
 
 
Net Cash Flow Investing-41.4M9.9M15.0M15.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale11.0K175.0K395.0K11.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing71.8M0.000.000.00
 
 
Other Uses - Financing1.5M0.000.000.00
 
 
Net Cash Flow - Financing70.3M175.0K395.0K11.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash21.0M2.5M6.4M3.4M